Zenith Goldline

Zenith Goldline Pharmaceuticals was a major American generic drug manufacturer formed by the merger of Zenith Laboratories and Goldline Laboratories in 1995 under the ownership of IVAX Corporation. The company specialized in the development, manufacturing, and marketing of a broad range of generic pharmaceutical products, primarily focusing on small molecule therapeutics. As one of the largest generic firms in the United States during the late 1990s, it provided cost-effective alternatives for widely prescribed medications in areas such as cardiovascular health and respiratory care. The company's operations were eventually integrated into IVAX Pharmaceuticals, which was subsequently acquired by Teva Pharmaceutical Industries in 2006. Today, the legacy of Zenith Goldline exists as part of Teva's extensive global generic portfolio.